background-splash

Tag: Pharvaris

A relative newcomer to the biotech scene, Pharvaris was founded by the team that successfully exited to BioMarin in 2015. With a promising pipeline, including treatments for rare diseases, Pharvaris is quickly gaining attention from investors and the medical community.

Never miss a new episode 💌

Trusted by 350+ professionals from top companies like Argenx, BioNTech, or Genmab. No spam, no noise.

Watch & Subscribe